(Carnegie Mellon University) A team, led by the University of California, Los Angeles' Ian Larkin and Carnegie Mellon University's George Loewenstein, examined restrictions at 19 academic medical centers placed on pharmaceutical representatives' visits to doctors' offices. Published in the Journal of the American Medical Association, the results reveal that the restrictions caused physicians to switch from prescribing drugs that were more expensive and patent-protected to generic, significantly cheaper drugs.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2pCe3y7
No comments:
Post a Comment